BRD 7116 inhibits LSCe (leukemia stem cell) and HSPCs (Hematopoietic stem cells ), by displaying cell-non-autonomous anti-leukemia activity.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.